Similar articles

• [Autoantibodies in systemic sclerosis].

  Genth E, Mierau R. Genth E, et al. Dtsch Med Wochenschr. 2012 Sep;137(36):1758-60. doi: 10.1055/s-0032-1305249. Epub 2012 Aug 29. Dtsch Med Wochenschr. 2012. PMID: 22933201 Review. German. No abstract available.
• [The cutting-edge of medicine; pathogenesis and treatment of systemic sclerosis].

  Sato S. Sato S. Nihon Naika Gakkai Zasshi. 2013 May 10;102(5):1226-32. doi: 10.2169/naika.102.1226. Nihon Naika Gakkai Zasshi. 2013. PMID: 23847990 Review. Japanese. No abstract available.
• Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.

  Moroncini G, Cuccioloni M, Mozzicafreddo M, Pozniak KN, Grieco A, Paolini C, Tonnini C, Spadoni T, Svegliati S, Funaro A, Angeletti M, Gabrielli A. Moroncini G, et al. Anal Biochem. 2017 Jul 1;528:26-33. doi: 10.1016/j.ab.2017.04.011. Epub 2017 Apr 24. Anal Biochem. 2017. PMID: 28450104
• Prognostic properties of anti-topoisomerase antibodies in patients identified by the ACR/EULAR 2013 systemic sclerosis criteria.

  Boonstra M, Ninaber MK, Ajmone Marsan N, Huizinga TWJ, Scherer HU, de Vries-Bouwstra JK. Boonstra M, et al. Rheumatology (Oxford). 2019 Apr 1;58(4):730-732. doi: 10.1093/rheumatology/kez005. Rheumatology (Oxford). 2019. PMID: 30690619 No abstract available.
• Serological profile of patients with systemic sclerosis.

  Wielosz E, Dryglewska M, Majdan M. Wielosz E, et al. Postepy Hig Med Dosw (Online). 2014 Aug 18;68:987-91. doi: 10.5604/17322693.1117543. Postepy Hig Med Dosw (Online). 2014. PMID: 25228505